Jo Varshney, PhD, DVM, discusses how VeriSIM Life’s innovative approach leverages artificial intelligence and multispecies data.
Jo Varshney, PhD, DVM
Advertisement
Jo Varshney, PhD, DVM, CEO and founder of VeriSIM Life.
Articles by Jo Varshney, PhD, DVM
Jo Varshney, PhD, DVM, discusses how artificial intelligence–powered simulations speed drug approvals and reduce clinical trial risk.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
How Often Do Health Insurers Deny Doctor-Recommended Care?
2
Acoramidis Shows Durable Benefit at 54 Months in ATTR-CM
3
Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story
4
What Managed Care Should Watch at ADA 2026 Scientific Sessions
5